Results 151 to 160 of about 2,148,975 (183)

Insights into Nodal T-Follicular Helper Cell lymphomas and Peripheral T-Cell Lymphomas, Not Otherwise Specified, in Slovenian Patients: Mutational Landscape, Clinicopathological Characteristics, and Outcomes. [PDF]

Ann Hematol
Erzar E, Sindi-Ivanova V, Dirnhofer S, Boltežar L, Ocvirk J, Kloboves Prevodnik V, Tzankov A, Gašljević G.   +7 more
europepmc   +1 more source

Genome-epigenome crosstalk in T-cell lymphomas: from maps to mechanisms. [PDF]

Int J Hematol
Yamagishi M.
europepmc   +1 more source

Immune Correlates of Denileukin Diftitox Treatment in TFH-Type Lymphoma. [PDF]

Cancers (Basel)
Jo T, Sakai T, Noguchi K, Yamaguchi K, Umemoto K, Matsuo M, Sawayama Y, Taguchi J, Kubota-Koketsu R, Abe K, Shigematsu K.   +10 more
europepmc   +1 more source

Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision Therapeutics. [PDF]

J Pers Med
Casan JML, Ong XJ, van der Weyden C, Yannakou CK, Zhu J, D'Souza C, Neeson P, Prince HM.   +7 more
europepmc   +1 more source

Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study. [PDF]

Blood Adv
Tournilhac O, Bouabdallah K, Lecolant S, Hacini M, Laribi K, Bailly S, Belmondo T, Maerevoet M, Ysebaert L, Guidez S, Le Gouill S, Bonnet C, André M, Dupuis J, Thieblemont C, Bachy E, Daguindau N, Morschhauser F, Tricot S, Moulin C, Banos A, Houot R, Chauchet A, Gyan E, Cartron G, Farhat H, Camus V, Drenou B, Zerazhi H, Sibon D, Nicolas-Virelizier E, Delette C, Snauwaert S, Bailly S, Delarue R, Carras S, Ledoux-Pilon A, Parrens MC, Griolet S, Gaulard P, Delfau-Larue MH, de Leval L, Damaj GL.   +42 more
europepmc   +1 more source

Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS

Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS
openaire  

Some of the next articles are maybe not open access.

Related searches:

A Rare Case of CD4 Positive Cytotoxic PTCL, NOS With Leukemic Presentation

International Journal of Surgical Pathology, 2023
Peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) is a relatively rare mature T-cell lymphoma that cannot be categorized under any of the well-defined category. This type of aggressive lymphoma mostly involves the lymph nodes, though any other organ can be affected. Leukemic presentation is extremely rare.
Jayati Mallick, Paul E Young, Kirill A Lyapichev   +2 more
exaly   +3 more sources

Clinicopathological analysis in PTCL-NOS with CADM1 expression

Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin, 2017
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS), is a heterogeneous disease with respect to clinicopathological features. Cell adhesion molecule 1 (CADM1) has been reported to be ectopically expressed in adult T cell leukaemia/lymphoma (ATLL). However, the frequency of CADM1 expression remains unknown in peripheral T cell lymphomas.
Takeharu Kato, Hiroaki Miyoshi, Seiichiro Kobayashi   +2 more
exaly   +3 more sources

Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL

Leukemia, 2022
Fit patients with peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) and angioimmunoblastic T-cell lymphoma (AITL) in relapsed or refractory (R/R) disease status often receive salvage chemotherapy followed by autologous hematopoietic stem cell transplantation (autoHCT) or allogeneic HCT (alloHCT).
Kazuaki Kameda, Shinichi Kako, Sung-Won Kim, Yoshiaki Usui, Koji Kato, Takahiro Fukuda, Naoyuki Uchida, Hikaru Kobayashi, Toshio Wakayama, Emiko Sakaida, Shingo Yano, Kazunori Imada, Miho Nara, Takashi Ikeda, Shin-ichi Fuchida, Jun Ishikawa, Hiroyuki Sugahara, Junya Kanda, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Eisei Kondo   +21 more
openaire   +2 more sources